PRICKLE2-AS1
geneOn this page
Summary
PRICKLE2-AS1 (PRICKLE2 antisense RNA 1, HGNC:40916) is a long non-coding RNA gene on chromosome 3p14.1.
At a glance
- Clinical variants (ClinVar): 77 total
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40916 |
| Approved symbol | PRICKLE2-AS1 |
| Name | PRICKLE2 antisense RNA 1 |
| Location | 3p14.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000241572 |
| Entrez | 100652759 |
| RNAcentral | URS000075DA3C — lncRNA, 6521 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Bgee: expression breadth broad, 86 present calls, max score 84.18.
Top tissues by expression
86 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.18 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 68.31 | gold quality |
| ganglionic eminence | UBERON:0004023 | 63.97 | gold quality |
| right testis | UBERON:0004534 | 61.62 | gold quality |
| left testis | UBERON:0004533 | 61.37 | gold quality |
| testis | UBERON:0000473 | 60.89 | gold quality |
| ventricular zone | UBERON:0003053 | 60.09 | gold quality |
| cortex of kidney | UBERON:0001225 | 56.62 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 56.29 | gold quality |
| kidney | UBERON:0002113 | 56.10 | gold quality |
| prefrontal cortex | UBERON:0000451 | 55.96 | gold quality |
| stromal cell of endometrium | CL:0002255 | 55.47 | gold quality |
| islet of Langerhans | UBERON:0000006 | 55.36 | gold quality |
| endocervix | UBERON:0000458 | 54.02 | gold quality |
| endometrium | UBERON:0001295 | 53.53 | gold quality |
| heart left ventricle | UBERON:0002084 | 52.95 | gold quality |
| liver | UBERON:0002107 | 52.73 | silver quality |
| muscle of leg | UBERON:0001383 | 52.62 | gold quality |
| monocyte | CL:0000576 | 52.21 | gold quality |
| gastrocnemius | UBERON:0001388 | 52.08 | gold quality |
| blood | UBERON:0000178 | 51.66 | silver quality |
| heart | UBERON:0000948 | 50.13 | gold quality |
| pancreas | UBERON:0001264 | 49.36 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 49.04 | gold quality |
| right lobe of liver | UBERON:0001114 | 48.90 | silver quality |
| multicellular organism | UBERON:0000468 | 48.74 | gold quality |
| right lung | UBERON:0002167 | 48.01 | gold quality |
| tibial artery | UBERON:0007610 | 47.70 | gold quality |
| stomach | UBERON:0000945 | 47.31 | gold quality |
| left coronary artery | UBERON:0001626 | 47.25 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
chr3p14, CBX5_TARGET_GENES, DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS, DESCARTES_FETAL_ADRENAL_SLC26A4_PAEP_POSITIVE_CELLS, DESCARTES_FETAL_EYE_PHOTORECEPTOR_CELLS
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 22 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
176 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:64099923:GGCCT:G | acceptor_loss | 1.0000 |
| 3:64099925:CCT:C | acceptor_loss | 1.0000 |
| 3:64099927:T:A | acceptor_loss | 1.0000 |
| 3:64099086:T:TA | donor_gain | 0.9900 |
| 3:64099921:GAGGC:G | acceptor_gain | 0.9900 |
| 3:64099922:AGGC:A | acceptor_gain | 0.9900 |
| 3:64099923:GGC:G | acceptor_gain | 0.9900 |
| 3:64099924:GC:G | acceptor_gain | 0.9900 |
| 3:64099925:CC:C | acceptor_gain | 0.9900 |
| 3:64099926:C:CC | acceptor_gain | 0.9900 |
| 3:64099063:A:AC | donor_gain | 0.9800 |
| 3:64099064:C:CC | donor_gain | 0.9800 |
| 3:64099077:T:TA | donor_gain | 0.9700 |
| 3:64099109:C:CT | donor_gain | 0.9700 |
| 3:64099926:C:T | acceptor_gain | 0.9700 |
| 3:64099105:TCTGC:T | donor_gain | 0.9400 |
| 3:64099106:CTGCC:C | donor_gain | 0.9400 |
| 3:64099385:T:A | donor_gain | 0.9400 |
| 3:64099107:TGC:T | donor_gain | 0.9100 |
| 3:64102708:T:TA | donor_gain | 0.8400 |
| 3:64099448:T:C | donor_gain | 0.8200 |
| 3:64099007:CATT:C | donor_gain | 0.7700 |
| 3:64099110:C:CT | donor_gain | 0.7600 |
| 3:64099008:A:C | donor_gain | 0.7500 |
| 3:64099002:CT:C | donor_gain | 0.7300 |
| 3:64099003:TT:T | donor_gain | 0.7300 |
| 3:64099004:TT:T | donor_gain | 0.7300 |
| 3:64099064:CAGTT:C | donor_gain | 0.7200 |
| 3:64099064:CA:C | donor_gain | 0.7000 |
| 3:64099675:T:TA | donor_gain | 0.6800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000059461 (3:64080805 G>A), RS1000090309 (3:64081100 T>C), RS1000218064 (3:64094345 T>C), RS1000364628 (3:64086498 C>A), RS1000378311 (3:64068641 T>G), RS1000462173 (3:64100663 T>C), RS1000554087 (3:64095701 C>A,G,T), RS1000634797 (3:64095381 T>C), RS1000640976 (3:64087760 T>C), RS1000727933 (3:64097460 T>A), RS1000785307 (3:64090855 C>T), RS1000900408 (3:64090976 C>T), RS1000973198 (3:64085055 C>G,T), RS1001065730 (3:64079449 A>G), RS1001095167 (3:64079663 C>T)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:254800
GenCC curated gene-disease
Mondo (2): myoclonic epilepsy (MONDO:0100577), progressive myoclonus epilepsy (MONDO:0020074)
Orphanet (3): Progressive myoclonic epilepsy type 5 (Orphanet:402082), Progressive myoclonic epilepsy type 1 (Orphanet:308), Progressive myoclonic epilepsy (Orphanet:98261)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D020191 | Myoclonic Epilepsies, Progressive | C10.228.140.490.375.130.650; C10.228.140.490.493.063.650 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| dimethylselenide | increases expression, increases oxidation | 1 |
| fipronil | affects cotreatment, decreases expression | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Ozone | increases expression, increases oxidation | 1 |
| Hydroxyl Radical | increases expression, increases oxidation | 1 |
Clinical trials (associated diseases)
3 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT00006191 | Not specified | COMPLETED | Effect of Levetiracetam on Brain Excitability |
| NCT06593951 | Not specified | RECRUITING | Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1) |
| NCT06923241 | Not specified | COMPLETED | Nutri-score Labelling in a UK Restaurant Setting: a Randomised Control Trial |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): myoclonic epilepsy, progressive myoclonus epilepsy